SEP-363856 (mesylate)
SEP-363856 (SEP-856) mesylate, an orally active TAAR1 and 5-HT1A agonist and CNS active psychotropic agent with a unique, non-D2/5-HT2A mechanism of action, exerts its antipsychotic-like effects. SEP-363856 mesylate has the potential for the study of schizophrenia[1].
Product Specifications
CAS Number
2375116-27-9
Product Name Alternative
SEP-856 (mesylate)
UNSPSC
12352005
Target
5-HT Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/sep-363856-mesylate.html
Smiles
CS(=O)(O)=O.CNC[C@H]1C2=C(CCO1)C=CS2
Molecular Formula
C10H17NO4S2
Molecular Weight
279.38
References & Citations
[1]Dedic N, et al. SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action. J Pharmacol Exp Ther. 2019 Oct;371 (1) :1-14.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
5-HT1 Receptor; mLAG-3; MUC3; α-1 microglobulin
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog